SOBI:STO
Swedish Orphan Biovitrum
436,60Â SEK
arrow_downward
-0,64%(-2,80) 1G
29 set, 17:29:41 GMT+2 · SEK
search
Tutti i simboli
1G
5G
1M
6M
YTD
1A
5A
MAX
| Simbolo | Prezzo | Cambio | % di cambio |
|---|
insights_autoGenerazione degli insight principali per SOBI in corso…
Apertura
438,80Â SEK
Massimo
443,40Â SEK
Minimo
435,00Â SEK
Cap. mercato
156,14Â Mld
Vol. medio
272,04K
Volume
198,48K
Rapporto P/E
116,61
Max 52 sett.
487,00Â SEK
Min 52 sett.
266,00Â SEK
Utili per azione
3,74Â SEK
Azioni in circolazione
357,41Â Mln
N. di dipendenti
2K
Apertura
438,80Â SEK
Massimo
443,40Â SEK
Minimo
435,00Â SEK
Cap. mercato
156,14Â Mld
Vol. medio
272,04K
Volume
198,48K
Rapporto P/E
116,61
Max 52 sett.
487,00Â SEK
Min 52 sett.
266,00Â SEK
Utili per azione
3,74Â SEK
Azioni in circolazione
357,41Â Mln
N. di dipendenti
2K
Profilo
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
Informazioni su Swedish Orphan Biovitrum